/R E P E A T -- Media Advisory - Minister Philpott to sign Memorandum of Understanding on Health with Onion Lake Cree Nation/
ONION LAKE CREE NATION, SK, May 16, 2018 /CNW/ - Please be advised that the Honourable Jane Philpott, Minister of Indigenous Services, and Okimaw Wallace Fox, Chief of Wicekaskosiw Sakahikan Nehiyaw Askiy (Onion Lake Cree Nation) will participate in the signing of a Memorandum of Understanding to support health care transformation for Onion Lake communities.
A brief media availability will take place following the announcement.
Date: May 17, 2018
Time: 9:45 a.m. ? 12:00 p.m. (MDT)
Please note that because this is a ceremonial event, media will be permitted to set up at 11:15 a.m. with no recording, live feeds or broadcasting before then.
Where: Onion Lake Cree Nation Communiplex, Junction of Highway #17 and secondary Highway #797 Treaty 6 Territory, Saskatchewan
Exegenesis Bio, a rapidly growing global genetic medicines company, is pleased to announce the presentation of clinical efficacy and safety data from its EXG001-307 Phase 1/2 clinical trial in Spinal Muscular Atrophy (SMA) Type I at the American...
BioAro, a pioneer in genomic research and technology, is set to officially launch PanOmiQ, a revolutionary software that will redefine the landscape of genomic analysis globally by providing real-time insights into the complexities of the human...
Pleio, Inc. and FountainRx announce their partnership to provide a concierge-level experience to specialty pharmacy patients. The two companies are launching a program to provide patients with human-driven support as they onboard onto their specialty...
JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today released a Virtual Investor "What This Means" segment featuring Moleculin Biotech , a clinical stage pharmaceutical company with a...
Hyundai Bioscience announced on April 25th that, after multiple consultations with global clinical research organizations (CRO), it has decided to conduct clinical trials for its 'niclosamide-based Dengue antiviral' in...
Inocras, a leading AI-driven whole genome testing company, proudly announces the launch of CancerVision and RareVision, its flagship whole genome diagnostics solutions in solid tumor cancer and rare disease, respectively.
CancerVision and...
